Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of shared variants between cancer biospecimens.
Foote MB, White JR, Chatila WK, Argilés G, Lu S, Rousseau B, Artz O, Johannet P, Walch H, Patel M, Lamendola-Essel MF, Casadevall D, Abdelfattah S, Patel S, Yaeger R, Cercek A, Montagut C, Berger M, Schultz N, Diaz LA. Foote MB, et al. Among authors: walch h. Clin Cancer Res. 2024 Nov 19. doi: 10.1158/1078-0432.CCR-24-1583. Online ahead of print. Clin Cancer Res. 2024. PMID: 39561276
The Impact of Germline Alterations in Appendiceal Adenocarcinoma.
Foote MB, Walch H, Kemel Y, Vakiani E, Johannet P, Sheehan M, Chatila W, Chung S, Nash GM, Maio A, Shia J, Mandelker D, Berger M, Schultz N, Diaz LA, Cercek A, Stadler ZK. Foote MB, et al. Among authors: walch h. Clin Cancer Res. 2023 Jul 14;29(14):2631-2637. doi: 10.1158/1078-0432.CCR-22-3956. Clin Cancer Res. 2023. PMID: 37289003 Free PMC article.
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors.
Johannet P, Abdelfattah S, Wilde C, Patel S, Walch H, Rousseau B, Argiles G, Artz O, Patel M, Arfe A, Cercek A, Yaeger R, Ganesh K, Schultz N, Diaz LA, Foote MB. Johannet P, et al. Among authors: walch h. J Clin Oncol. 2024 Nov 10;42(32):3847-3857. doi: 10.1200/JCO.24.00186. Epub 2024 Aug 9. J Clin Oncol. 2024. PMID: 39121438
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
Sihag S, Nussenzweig SC, Walch HS, Hsu M, Tan KS, Sanchez-Vega F, Chatila WK, De La Torre SA, Patel A, Janjigian YY, Maron S, Ku GY, Tang LH, Hechtman J, Shah PM, Wu AJ, Jones DR, Molena D, Solit DB, Schultz N, Berger MF. Sihag S, et al. Among authors: walch hs. Clin Cancer Res. 2021 Jun 15;27(12):3491-3498. doi: 10.1158/1078-0432.CCR-20-4707. Epub 2021 Apr 1. Clin Cancer Res. 2021. PMID: 33795256 Free PMC article.
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.
Sihag S, Nussenzweig SC, Walch HS, Hsu M, Tan KS, De La Torre S, Janjigian YY, Maron SB, Ku GY, Tang LH, Shah PM, Wu A, Jones DR, Solit DB, Schultz N, Ganesh K, Berger MF, Molena D. Sihag S, et al. Among authors: walch hs. Clin Cancer Res. 2022 Jun 13;28(12):2669-2678. doi: 10.1158/1078-0432.CCR-21-4016. Clin Cancer Res. 2022. PMID: 35377946 Free PMC article.
Molecular Classification of Appendiceal Adenocarcinoma.
Foote MB, Walch H, Chatila W, Vakiani E, Chandler C, Steinruecke F, Nash GM, Stadler Z, Chung S, Yaeger R, Braghrioli MI, Shia J, Kemel Y, Maio A, Sheehan M, Rousseau B, Argilés G, Berger M, Solit D, Schultz N, Diaz LA Jr, Cercek A. Foote MB, et al. Among authors: walch h. J Clin Oncol. 2023 Mar 10;41(8):1553-1564. doi: 10.1200/JCO.22.01392. Epub 2022 Dec 9. J Clin Oncol. 2023. PMID: 36493333 Free PMC article.
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer.
Harrold E, Keane F, Walch H, Chou JF, Sinopoli J, Palladino S, Al-Rawi DH, Chadalavada K, Manca P, Chalasani S, Yang J, Cercek A, Shia J, Capanu M, Bakhoum SF, Schultz N, Chatila WK, Yaeger R. Harrold E, et al. Among authors: walch h. Clin Cancer Res. 2024 Jun 14;30(12):2672-2683. doi: 10.1158/1078-0432.CCR-23-4005. Clin Cancer Res. 2024. PMID: 38502113 Free PMC article.
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.
Maron SB, Chatila W, Walch H, Chou JF, Ceglia N, Ptashkin R, Do RKG, Paroder V, Pandit-Taskar N, Lewis JS, Biachi De Castria T, Sabwa S, Socolow F, Feder L, Thomas J, Schulze I, Kim K, Elzein A, Bojilova V, Zatzman M, Bhanot U, Nagy RJ, Lee J, Simmons M, Segal M, Ku GY, Ilson DH, Capanu M, Hechtman JF, Merghoub T, Shah S, Schultz N, Solit DB, Janjigian YY. Maron SB, et al. Among authors: walch h. Clin Cancer Res. 2023 Sep 15;29(18):3633-3640. doi: 10.1158/1078-0432.CCR-22-3769. Clin Cancer Res. 2023. PMID: 37406106 Free PMC article. Clinical Trial.
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier.
Song Y, Boerner T, Drill E, Shin P, Kumar S, Sigel C, Cercek A, Kemeny N, Abou-Alfa G, Iacobuzio-Donahue C, Cowzer D, Schultz N, Walch H, Balachandran V, Groot Koerkamp B, Kingham P, Soares K, Wei A, D'Angelica M, Drebin J, Chandwani R, Harding JJ, Jarnagin W. Song Y, et al. Among authors: walch h. Clin Cancer Res. 2024 Aug 15;30(16):3499-3511. doi: 10.1158/1078-0432.CCR-24-0657. Clin Cancer Res. 2024. PMID: 38864854
96 results